Vaxart, Inc. (NASDAQ:VXRT) Q4 2025 Earnings Call Transcript March 12, 2026 Vaxart, Inc. beats earnings expectations. Reported EPS is $0.239, expectations were $-0.08. Operator: Greetings, and welcome ...
VAXART ($VXRT) posted quarterly earnings results on Thursday, March 20th. The company reported earnings of -$0.05 per share, beating estimates of -$0.10 by $0.05. The ...
Vaxart (VXRT) has shared an announcement. Vaxart, Inc. stockholders have given the green light for significant expansions to the company’s equity plans and an increase in authorized shares. This move, ...
Oppenheimer initiated coverage on Vaxart Inc. (NASDAQ:VXRT), an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines. The analyst’s ...
Vaxart Inc (NASDAQ:VXRT) shares are trading higher in Monday’s after-hours session after the company provided business and cash runway updates. What Happened: Vaxart, a clinical-stage biotechnology ...
Vaxart (NASDAQ:VXRT) just reported results for the first quarter of 2024. Vaxart reported earnings per share of -14 cents. This met the analyst estimate for EPS of -14 cents. The company reported ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results